Aerosolized aldesleukin
Term · Oncology and biomedicine · MLC-T-ONC-009720
An aerosol formulation of aldesleukin, a recombinant form of interleukin-2 (IL-2), with potential immunostimulating activity. Upon IL-2 inhalation, this cytokine activates lymphokine-activated killer cells and natural killer cells, and induces expression of cytotoxic cytokines, such as interferon-gamma and transforming growth factor-beta. This may eventually halt tumor cell growth. Localized administration of IL-2 may decrease toxicity and increase efficacy.
| Identifier | MLC-T-ONC-009720 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | aerosolized recombinant IL-2 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009720",
"term": "Aerosolized aldesleukin",
"field": "Oncology and biomedicine",
"definition": "An aerosol formulation of aldesleukin, a recombinant form of interleukin-2 (IL-2), with potential immunostimulating activity. Upon IL-2 inhalation, this cytokine activates lymphokine-activated killer cells and natural killer cells, and induces expression of cytotoxic cytokines, such as interferon-gamma and transforming growth factor-beta. This may eventually halt tumor cell growth. Localized administration of IL-2 may decrease toxicity and increase efficacy.",
"synonyms": [
"aerosolized recombinant IL-2"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/aerosolized-aldesleukin/"
}
Record 511 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.